Loading...
Products:Epigenetics and Nuclear Signaling >> DNA / RNA >> DNA Damage & Repair >> DNA Damage Response >> Chk1 / Chk2
If your product does not perform as described on this datasheet, we will refund or replace your product...
Read our guarantee »Anti-Chk2 antibody
See all Chk2 products (27) ...
Rabbit polyclonal to Chk2
WB, ICC/IFmore details
Reacts with
Mouse, Rat, Human
Synthetic peptide: SRESDVEAQQSHGSSAC, corresponding to amino acids 2-18 of Human Chk2.
SRESDVEAQQSHGSSAC
Jurkat or K562 cell lysate.
Liquid
Store at +4°C.
PBS with 0.02% sodium azide
Concentration information loading...
IgG fraction
Polyclonal
IgG
Cancer >> Cell cycle >> Kinases/phosphatases >> Other
Epigenetics and Nuclear Signaling >> DNA / RNA >> DNA Damage & Repair >> DNA Damage Response >> Chk1 / Chk2
Our Abpromise guarantee covers the use of ab8108 in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
WB: Use a concentration of 0.5 - 1 µg/ml. Detects a band of approximately 60 kDa (predicted molecular weight: 61 kDa).Can be blocked with Chk2 (N-term) peptide (human) (ab6088).
ICC/IF: Use a concentration of 1 µg/ml.
Regulates cell cycle checkpoints and apoptosis in response to DNA damage, particularly to DNA double-strand breaks. Inhibits CDC25C phosphatase by phosphorylation on 'Ser-216', preventing the entry into mitosis. May also play a role in meiosis. Regulates the TP53 tumor suppressor through phosphorylation at 'Thr-18' and 'Ser-20'.
High expression is found in testis, spleen, colon and peripheral blood leukocytes. Low expression is found in other tissues.
Defects in CHEK2 are associated with Li-Fraumeni syndrome 2 (LFS2) [MIM:609265]; a highly penetrant familial cancer phenotype usually associated with inherited mutations in p53/TP53.
Defects in CHEK2 may be a cause of susceptibility to prostate cancer (PC) [MIM:176807]. It is a malignancy originating in tissues of the prostate. Most prostate cancers are adenocarcinomas that develop in the acini of the prostatic ducts. Other rare histopathologic types of prostate cancer that occur in approximately 5% of patients include small cell carcinoma, mucinous carcinoma, prostatic ductal carcinoma, transitional cell carcinoma, squamous cell carcinoma, basal cell carcinoma, adenoid cystic carcinoma (basaloid), signet-ring cell carcinoma and neuroendocrine carcinoma.
Defects in CHEK2 are found in some patients with osteogenic sarcoma (OSRC) [MIM:259500].
Belongs to the protein kinase superfamily. CAMK Ser/Thr protein kinase family. CHK2 subfamily.
Contains 1 FHA domain.
Contains 1 protein kinase domain.
Phosphorylated by PLK4.
Nucleus; Nucleus. Isoform 10 is present throughout the cell and Nucleus > PML body. Nucleus > nucleoplasm. Recruited into PML bodies together with TP53.
Target information above from: UniProt accessionO96017
The UniProt Consortium
The Universal Protein Resource (UniProt) in 2010
Nucleic Acids Res. 38:D142-D148 (2010).
Western blot - Chk2 antibody (ab8108)

All lanes : Anti-Chk2 antibody (ab8108) at 1 µg/ml
Lane 1 : K562 whole cell lysate
Lane 2 : Jurkat whole cell lysate
Lane 3 : HL-60 whole cell lysate
Predicted band size : 61 kDa
Immunocytochemistry/ Immunofluorescence - Chk2 antibody (ab8108)

ab8108 at 1µg/ml staining Chk2 in Jurkat cells by ICC/IF
Immunocytochemistry/ Immunofluorescence - Chk2 antibody (ab8108)

ab8108 (1/100) staining Chk2 in HeLa cells (green). Cells were fixed in paraformaldehyde, permeabilised with 0.5% Triton X-100/PBS and counterstained with DAPI in order to highlight the nucleus (red). Please refer to abreview for further experimental details.
This image is courtesy of an Abreview submitted by Dr Kirk McManus
This product has been referenced in:
See all 13 publications for this product
Publishing research using ab8108? Please let us know so that we can cite the reference in this datasheet
Concentration of lot no. is
Concentration not available for this lot.
Find concentration of your lot:

ab8108 at 1µg/ml staining Chk2 in Jurkat cells by ICC/IF

ab8108 (1/100) staining Chk2 in HeLa cells (green). Cells were fixed in paraformaldehyde, permeabilised with 0.5% Triton X-100/PBS and counterstained with DAPI in order to highlight the nucleus (red). Please refer to abreview for further experimental details.
This image is courtesy of an Abreview submitted by Dr Kirk McManus
3
Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"
Call 01223 696 000 or contact us
